Table 1.
Clinicopathologic data of the effusion cohort (56 patients).
| Parameter | ||
|---|---|---|
|
| ||
| Age | Mean (range) | Number of patients 61 (38–79) |
| FIGO stage | III | 28 |
| IV | 28 | |
|
| ||
| Grade | Low | 4 |
| High | 46 | |
| NA a | 6 | |
|
| ||
| Residual disease | ≤1 cm | 20 |
| >1 cm | 28 | |
| NA b | 8 | |
|
| ||
| Chemotherapy status c | Pre-chemotherapy | 30 |
| Post-chemotherapy | 31 | |
|
| ||
| Chemotherapy response at diagnosis | Complete | 33 |
| Non-complete d | 16 | |
| Other e | 7 | |
a
NA means not available, including effusions from inoperable patients where biopsy was too small for grading or patients were operated on in other hospitals, for which the primary tumor could not be accessed for assessment of grade;
b
NA means not available, including patients operated on in other hospitals and patients with no record;
c
For 61 effusions;
d
Partial response, stable disease or progression;
e
Allergic or adverse reaction or non-measurable response.